Wednesday, 1st November Clinical Oncology Society of Australia Annual Scientific Meeting 2023

• Navigating the pathways: patterns of care for all women with gynaecological cancer in Queensland  - Rhett Morton
• Ensuring equity: monitoring health outcomes for Queensland First Nations women with cervical and endometrial cancer - Tamara Butler
• Trends in the utilisation of brachytherapy in cervical cancer in Queensland: how do we compare?  - Penny Mackenzie
• Increased endometrial cancer rates: the link between obesity and endometrial cancer risk  - Shaun McGrath

This symposium will highlight current work and impart practical strategies to support the implementation of evidence-based nutrition and exercise recommendations, including:

• Development of a toolkit to support implementation of the COSA Cancer-related Malnutrition and Sarcopenia Position Statement recommendations

• Presentations from the inaugural COSA Nutrition-Exercise Fellows on the establishment of a detailed map of the nutrition and exercise services available in cancer centres in Australia

• Evidence to practice: highlight on nutrition

• Evidence to practice: highlight on exercise

• Strategies to help support clinicians and health services implement evidence-based nutrition and exercise recommendations

This session will include interactive Q&A with all speakers.

Speakers:

• Prof. Judy Bauer - Evidence to practice: highlight on nutrition
• Dr Mary Kennedy - Evidence to practice: highlight on exercise
• Jane Stewart - Development of a toolkit to support implementation of the Clinical Oncology Society of Australia Malnutrition and Sarcopenia Position Statement recommendations
• Dr Emily Jeffrey (COSA Nutrition Fellow) - Introducing the COSA Nutrition Fellow project
• Dr Kim Edmunds (COSA Exercise Fellow) - Introducing the COSA Exercise Fellow project

• Prevalence of Australians exposed to potentially cardiotoxic cancer medicines: a population-based cohort study - Maria Aslam
• Making Metastatic Breast Cancer Count: Barriers, enablers and key recommendations identified through expert interviews and a national roundtable - Vicki Durston
• Linking data from a brain cancer clinical registry (BRAIN) with the state-based registry of Births Deaths Marriages: Improving the quality of clinical registry survival data  - Samuel Smith
• Patterns of mental health service utilisation in people with cancer compared with people without cancer: the Australian National Study of Mental Health and Wellbeing analysis - Huah Shin Ng
• Patterns of treatment and survival outcomes for people diagnosed with glioblastoma: a population-based study in Queensland - Suzanne Poulgrain
• Modifiable risk factors for cancer among people with Lynch syndrome: an international, cross-sectional survey - Robert F Power
• Benchmarking statewide cancer data: A comparison of breast and gynecological cancer care indicators between Victoria and Queensland - Euan Walpole

• Myokine response to high intensity interval exercise and relationships with body composition and cardiorespiratory fitness in cancer survivors - Morgan J Farley
• Correlation of Quantitative Emphysema and Lung Nodules on Low-dose CT (LDCT) in the Sydney Cohort of International Lung Screening Trial (ILST) - Wing Kwan Winky Lo
• “My Life Now is... “; Benefits of group-based exercise in adolescent and young adult cancer survivors in their own words. - Claire Munsie
• Fitness, body composition and HRQoL in long-term survivors of adolescent and young adult (AYA) cancers. - Andrew Murnane
• A multi-institutional study on long-term incidence of contralateral second breast cancer following breast cancer radiation therapy – Preliminary results. - Prabhakar Ramachandran
• What do Australian oncology health professionals know and practice regarding advance care planning?  - Helena Rodi
• Do young people who survive cancer, identify as ‘survivors’? Prevalence and predictors of cancer-related identities among adolescents and young adults following cancer. - Ursula M Sansom-Daly

Welcome by COSA President
Welcome to Country
Official opening by Her excellency Professor the Honourable Margaret Gardner AC Governor of Victoria

Chair: Fran Boyle

• Lessons learned over 50 years- reflections on the progress in improving outcomes of Australians with ovarian cancer and the opportunities and challenges ahead - Michael Friedlander
• Nurse-led interventions in breast and gynaecological cancers: Where to from here? - Meinir Krishnasamy
• Diagnosis and treatment of very early breast cancer - Bruce Mann
• How can we improve future cancer outcomes with big data and analytics? - Darren Brenner

10:20 AM Panel discussion

• Fertility preservation for cancer patients: light at the end of the tunnel - Kate Stern
• Supporting informed decision making in the fertility preservation process including work on fertility decision aids and the FORECAST study - Michelle Peate
• POSITIVE news for women after breast cancer   - Christobel Saunders
• Ovarian toxicity assessment in cancer clinical trials - where are we now? - Wanda Cui

12:00 PM Panel discussion

Chair: Ray Chan

• Pharmacist led prescribing clinics: The service framework  - Faye Coe
• Culturally Safe Multidisciplinary Care - Jordan Casey
• Sharing is caring: Models of Shared Care - Michael Jefford
• Surviving Cancer with a Community around Us - Vivienne Interrigi

12:20 PM Panel discussion

• Designing and implementing a paediatric cardio-oncology clinic using Delphi consensus driven guidelines as a model to guide care - Ben Felmingham
• Development of patient resources on cardiovascular health for Aboriginal and Torres Strait Islander people living with and beyond cancer - Abbey Diaz
• The Role of Exercise to Mitigate Cardiovascular Disease in Cancer Survivors - Erin Howden
• Cardio-Oncology:  Prevention is better than cure - Alexandra Murphy

12:00 PM Panel discussion

• Sino-nasal Undifferentiated Carcinoma (SNUC) in Queensland: a state-wide review from 1982 to 2021 - Bryan A Chan
• Towards an estimate of the prevalence of lymphoedema in Australia - Katherine Faulks
• Can metformin reduce the risk of aggressive prostate cancer? Results from the 45 and Up Study. - Visalini Nair-Shalliker
• Metastatic breast cancer (mBC) prevalence in New South Wales (NSW) estimated from two population-based breast cancer cohorts: a health record linkage study, 2001-2016 - Andrea L Smith
• Patterns of cardiovascular medication utilisation in people with cancer: the Australian National Health Survey linked data analysis - Jin Quan Eugene Tan
• Patterns of Care and Health Service Costs for Adolescent and Young Adults Cancer Survivors in Queensland - Carla Thamm

• Modifiable Lifestyle Behaviours and Biomarkers of Inflammation and Insulin Resistance in Female Breast Cancer Survivors Participating in a Weight Loss Trial. - Kelly D'cunha
• Alignment with the early detection phase of the Optimal Care Pathways is associated with improved outcomes for women with breast cancer - Norah Finn
• High Vs Low Load Resistance Exercise For Breast Cancer-Related Lymphedema: A Randomised Controlled Trial - Caitlin I Fox-Harding
• Real world analysis of breast cancer patients qualifying for adjuvant CDK4/6 inhibitors - Yada Kanjanapan
• Genitourinary symptoms in women with breast cancer: patients’ attitudes and experiences - Antonia Pearson
• The impact of real-time Patient Reported Outcome Measures (PROMs) on Emergency Department presentations in people with breast cancer - Kate Webber

COSA NETs Group Meeting                                                                 Meeting Room 104

COSA Survivorship Group Meeting                                                      Meeting Room 105

• Decisions and Prompts to Screen for Cervical, Bowel and Breast Cancer - Leah Zajdlewicz
• Cancer-associated mesenchymal stem cells promote Proliferation in Chemo-Radio-resistant Cervical Cancer cells - Shalmoli Bhattacharyya
• Identifying MET exon 14 skipping mutations in squamous cell lung cancer patients. - Carina Chan
• Medical Imaging Simulated Radiation Therapy: Improving access to palliative Radiation Therapy in WNSWLHD - Matthew Fuller
• Dashboards to deliver data-driven dietetics in the digital age: Translation of evidence-based nutrition guidelines into practice - Merran Findlay
• Emerging therapeutic potential of Vardhamana Pippali Rasayana (Ayurvedic Drug) in breast cancer - Subhash Gupta
• Feasibility and preliminary efficacy of brief coaching calls in Healthy Living after Cancer Online: a randomised control trial - Morgan Leske
• Investigating LGBTIQA+ Inclusion in Victorian Cancer Care: an incomplete picture. - Ashley Macleod
• Implementation Of Eccentric Exercise Programs As Therapy During Cancer – A Scoping Review  - Georgios Mavropalias
• Perioperative and Oncological Outcomes of Patients Undergoing Post-Chemotherapy Robotic-Retroperitoneal Lymph Node Dissection for Management of Primary Testicular Cancer - Navid Ahmadi
• Perioperative and Oncological Outcomes of Patients Undergoing Primary Robotic-RPLND For Management of Primary Testicular Cancer   - Navid Ahmadi
• Efficacy of celecoxib as an anticancer drug examined in the murine CT26 metastatic colorectal cancer model   - Reem ALHulais
• Providing early access to geriatric oncology services in a regional cancer centre – An evaluation of a newly established Nurse-Navigator led Geriatric Oncology Service Model and associated safety outcomes. - Dinuka Ariyarathna
• Dostarlimab for Primary Advanced or Recurrent (A/R) Endometrial Cancer (EC): Outcomes by Blinded Independent Central Review (BICR) of the RUBY trial - Ashish Banerjee
• Association between clinical outcomes and PSMA PET metrics in patients with metastatic prostate cancer  - Greta K Beale
• Immunotherapy in the setting of metastatic cutaneous squamous cell carcinoma – An OncoGeriatrics Perspective - Cassie Beaven
• An evaluation of time to treatment with adjuvant chemotherapy in high-risk early breast cancer patients in a regional setting - Cassie Beaven
• IMPROVING ACCESS TO TRIALS: A RAPID CASE ASCERTAINMENT TOOL USED TO IDENTIFY PATIENTS FOR RECRUITMENT - Maria Bechelli
• Role of 18F-FDG PET/CT for inital staging and treatment planning in pediatric sarcomas - Anish Bhattacharya
• Prehabilitation improves nutritional and muscle parameters prior to oesophago-gastric cancer surgery  - Jaimee Cacic
• Real-world disease characteristics, testing patterns and first-line treatment in RET fusion-positive advanced Non-Small Cell Lung Cancer in Australia - Felicity Casey
• Association between perioperative factors and DAH₃₀ in oncology patients undergoing hepatobiliary resection: a retrospective cohort study - David Chen
• The feasibility of pelvic floor muscle training to treat urinary incontinence in women with breast cancer: a telehealth intervention trial. - Udari Colombage
• Prehabilitation reduces postoperative surgical complications following oesophago-gastric cancer surgery - Kate Crombie
• What is ‘actual racism’- Healthcare workers perceptions of race and racism - Ieta D'Costa
• HER2 testing in advanced gastric cancer – understanding and reducing variation in current practice to improve equity patient outcomes - Bianka D'souza
• A phase 1b/2 study of OP-1250, an oral complete estrogen receptor (ER) antagonist (CERAN) and selective ER degrader (SERD) with palbociclib in patients (pts) with advanced or metastatic ER-positive, HER2-negative breast cancer (MBC)  - Daphne Day
• A Phase 1 (Ph1) Study of the OX40 Agonist, BGB-A445, With or Without Tislelizumab, an Anti-PD-1 Monoclonal Antibody (mAb), in Patients With Advanced Solid Tumors - Daphne Day
• Solving Unknown Primary cancER (SUPER): A cohort study - moving digital and adapting to challenges - Christine Dijkstra
• A Combined Exercise and Sedentary Behaviour Intervention Preserves VO_2peak in Adults Undergoing Allogeneic Stem Cell Transplantation for Haematological Cancer - Hayley T Dillon
• Updated efficacy and safety of lenvatinib (LEN) + pembrolizumab (pembro) vs treatment of physician’s choice (TPC) in patients (pts) with advanced endometrial cancer (aEC): Study 309/KEYNOTE-775 - Bas Ebaid
• Exercise capacity prior to major cancer surgery: A cross-sectional observational study of the validity of the six-minute walk and 30-second sit-to-stand tests - Linda Denehy
• Treatment sequencing in the VISION study of tepotinib in patients with MET exon 14 (METex14) skipping NSCLC - Stephanie Gasking
• Exploring management of elderly patients with glioblastoma using data from 2 randomised trials (GEINO1401/EX-TEM) - Lucy Gately
• Cancer-related cognitive impairment in patients with newly diagnosed aggressive lymphoma compared to healthy controls: An exploratory study - Priscilla Gates
• COLONY STIMULATING FACTORS TO TREAT FEBRILE NEUTROPENIA: WHAT DO WE KNOW AND WHAT SHOULD WE BE DOING? - Lilian Gauld
• Scrutinizing the whole genome for potential genes to design an African exclusive prostate cancer germline panel - Kazzem Gheybi
• Adjuvant immunotherapy for resected Stage IIIB-IV melanoma; real world efficacy, toxicity, hospitalisation rates and steroid use - Lee-att Green
• An Indian experience of safety and Efficacy of trastuzumab in HER2+ve breast cancer patients in real world settings - Subhash Gupta
• An observational study of frailty, associated factors and outcomes in older adults with and without a cancer diagnosis in an acute medical unit - Chad Han
• Energy expenditure in upper gastrointestinal cancer: A scoping review - Lauren Hanna
• COLUMBUS 7-Year Update: A Randomised, Open-Label, Phase 3 Trial of Encorafenib (Enco) + Binimetinib (Bini) vs Vemurafenib (Vemu) or Enco in Patients (Pts) With BRAF V600–Mutant Melanoma - Andrew Haydon
• Interventions to support patient decision making about taking part in health research: a systematic review - Jolyn Hersch
• An untold story about living with low muscle mass and its impact throughout curative radiotherapy treatment for lung cancer - Nicole Kiss
• Comparison of Fluorouracil (5FU) versus Capecitabine (Cape) as causative agents for admission in colorectal cancer (CRC) at the Princess Alexandra Hospital (PAH)  - Alexandra Knesl
• A comparison of carboplatin dosing between Cockcroft-Gault equation versus BSA-adjusted eGFR_CKD-EPI equation  - Neil Lam
• Complete and partial responses to azacitidine and carboplatin priming for ipilimumab and nivolumab re-challenge in patients with advanced melanoma who are resistant to immunotherapy. - Andre van der Westhuizen
• Lenvatinib vs sorafenib in the first-line treatment of patients with unresectable hepatocellular carcinoma (uHCC) and nonviral etiology: REFLECT post-hoc analysis - Chunyan Ma
• A phase 1b study of E7386, a CREB-binding protein/β-catenin interaction inhibitor, plus lenvatinib in patients with advanced hepatocellular carcinoma (HCC) - Chunyan Ma
• Real-world survival outcomes of first line pembrolizumab plus chemotherapy for metastatic Non-Small Cell Lung Cancer (NSCLC) in Australia - Wing Tung Michelle Ma
• Primary thoracic aorta angiosarcoma presenting with thromboembolism and progressive claudication despite anticoagulation - Jane McKenzie
• Immune-checkpoint inhibitors for locally-advanced and metastatic cutaneous squamous-cell carcinomas in a real-world Australian cohort - Luke S McLean
• Assessment of perineural spread in advanced cutaneous squamous cell carcinoma treated with immunotherapy - Luke S McLean
• Checkpoint inhibitor rechallenge following significant toxicity - can it be done successfully? - Tara McSweeney
• Experiences and decision-making perspectives of the informal carers of older adults with cancer - Erin Moth
• Demographic characteristics of culturally and linguistically diverse (CALD) cancer patients enrolled in early phase clinical trials in South Western Sydney - Woo Jun Park
• Tepotinib + osimertinib in EGFR-mutant NSCLC with MET amplification following 1L osimertinib: INSIGHT 2 primary analysis - Nick Pavlakis
• Tepotinib + osimertinib in EGFR-mutant NSCLC with MET amplification following 1L osimertinib: INSIGHT 2 primary analysis - Nick Pavlakis
• Population-Based Glioblastoma Treatment Outcomes in Regional Victoria - Graham Pitson
• Retrospective audit of clinicopathological features and treatment in early-stage NSCLC – A real-world analysis of patient atezolizumab eligibility - Lucy Porter
• Carboplatin dosing - Impact of the eviQ ADDIKD Guidelines - Benjamin N Rao
• C-POST protocol update: A phase 3, randomised, double-blind study of adjuvant cemiplimab versus placebo post surgery and radiation therapy in patients with high-risk cutaneous squamous cell carcinoma - Danny Rischin
• Comparative Analysis of Survival Outcomes and Prognostic Significance of Brain Metastasis in Lung Cancer Patients across Gippsland   - Bhavini Shah
• Patterns of care and outcomes in triple negative breast cancer: a retrospective study - Suman Bhasker
• Evaluating the utility of 2-Deoxy-2-[F-18]fluoro-D-glucose Positron Emission Tomography/Computer Tomography in Cancer of Unknown Primary. - Tharani Sivakumaran
• Physical activity levels 30 days following allogeneic and autologous bone marrow transplant - Christopher Swain
• Cancer Nutrition and Exercise rehabilitation program (CaNE) for patients with advanced cancer at risk of cancer cachexia syndrome: qualitative findings - Sim Yee (Cindy) Tan
• Feasibility study to compare taste changes and dietary intake in patients with head and neck cancer according to genetically determined Taster Status - Elise Treleaven
• Real-world data from early access and patient access programs of avelumab first-line maintenance treatment in patients with locally advanced or metastatic urothelial carcinoma in Australia - Annalisa Varrasso
• Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (aUC): long-term outcomes from the JAVELIN Bladder 100 trial in older patients - Annalisa Varrasso
• Treatment patterns and criteria used to determine platinum eligibility in metastatic urothelial cancer: a real-world survey in Australia - Annalisa Varrasso
• Implementation and evaluation of a geriatric-oncology model of care for older patients with lung cancer - Shalini K Vinod
• Incidence of Febrile Neutropenia and Time to Count Recovery in Patients with Acute Myeloid Leukaemia receiving Pegylated G-CSF following High-Dose Cytarabine (HiDAC) Consolidation - Madeleine Washbourne
• Barriers and enablers to the uptake of referrals to allied health services by older people with cancer. - Adam P Whibley
• A Case of Immunotherapy-Induced Epiglottitis - Colin Williams
• Ribociclib and endocrine therapy as adjuvant treatment in patients with HR+/HER2− early breast cancer: primary results from the phase III NATALEE trial - Belinda Yeo
• Can coronary artery calcium score identified on thoracic Radiotherapy planning CT scans be used and actioned to identify patients at high risk of cardiac events: a feasibility study in patients with cancer undergoing radiotherapy (RO-CARDIAC) - YVONNE ZISSIADIS
• Telehealth cognitive behaviour therapy for the management of sleep disturbance in women with early breast cancer receiving chemotherapy: a feasibility study - Emma-Kate Carson
• A novel ecological momentary assessment app for the investigation of cognitive function variability in breast cancer survivors - Annalee L Cobden
• Current physiotherapy practice around falls prevention in breast cancer care.    - Udari N Colombage
• Breast Cancer Screening Motivations and Behaviours for Women aged ≥ 75 years. - Jo Adams
• Pre-diagnosis beta-blocker use and breast cancer survival outcomes: a systematic review. - Mr Thomas Fontes Andrade
• A 10 year experience of cardiac toxicity in patients receiving HER2 directed therapies at a tertiary Australian centre - Daphne Day
• Changes in body weight during chemotherapy for early and metastatic breast cancer patients - Tamzin Hall
• Women’s views about current and future management of Ductal Carcinoma in Situ (DCIS): a mixed-methods study - Jolyn Hersch
• The value of left ventricular ejection fraction assessment prior to adjuvant or neoadjuvant anthracycline chemotherapy in breast cancer - Alison Hiong
• Demographic And Health Characteristics Associated With Likelihood Of Uptake Of Digitally-Delivered Cardiac Rehabilitation For Breast Cancer Survivors - Tamara Jones
• The impact of socioeconomic factors and social support on digital intervention engagement in people with breast cancer: a secondary data analysis. - Emma Kemp
• Robot-assisted education for Metastatic Breast Care Nurses: innovative upskilling for an evolving role. - Gillian Kruss
• A Multi-Method Evaluation of a Specialist Breast Nurse-Led Survivorship Clinic. - Gay M Refeld
• Sacituzumab Govitecan: Optimisation of Supportive Care Measures - Imogen IS Smith
• Clinical updates on the effects of high-intensity interval training (HIIT) exercise in people diagnosed with cancer. A systematic review and meta-analysis - Kellie Toohey
• Exploring patient and clinician perceptions of pre-clinic patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs) in breast oncology outpatient clinics. - Michelle White
• Surviving breast reconstruction: what information would help women?   - Victoria White
• Is telehealth pelvic floor muscle training feasible to treat incontinence after gynaecological cancer? - Robyn Brennen
• Prevalence and incidence of pelvic floor disorders before and after hysterectomy for gynaecological cancer - Robyn Brennen
• Associations between pelvic floor symptoms, physical activity and health-related quality-of-life 3-months after hysterectomy for gynaecological cancer - Robyn Brennen
• Exploring women’s experiences of receiving their cervical screening test results: A citizen science approach - Rachael H Dodd
• Associations among neighbourhood characteristics, quality of life, and activity behaviours among gynaecological cancer survivors in Nova Scotia, Canada - Cynthia Forbes
• Understanding what influences physical activity participation in women diagnosed with ovarian cancer: A qualitative study. - Gabrielle C Gildea
• Association of protein intake with recurrence and survival following primary treatment of ovarian cancer - Lizzy Johnston
• Fear of cancer recurrence in older women with gynaecological cancer at a regional cancer centre - Senara Kulatunga
• Can a self-guided online intervention for fear of cancer recurrence (iConquerFear) be feasibly, acceptably, and safely delivered to women affected by ovarian cancer? Results from a pilot randomised wait-list controlled trial - Ben Smith
• The inter-relationship between treatment-related adverse effects and exercise therapy in ovarian cancer survivors: exploratory findings from the ECHO Trial - Rosalind Spence
• Sharing lived experience to shape the future of gynaecological cancer care  - Bree Stevens
• Feasibility of Measurement of Quality Indicators for the management of Cervical Cancer in New South Wales - Shalini K Vinod
• The Growth and Adaptation of a National Cancer Nurse Practitioner Network - Gillian Blanchard
• Message from Matt: The power of the lived experience in educating health professionals - Jo Collins
• Early Phase Clinical Trials information: Recommendations for equitable resources - Duncan Colyer
• "Knowing my scope": Development and evaluation of an allied health cancer rehabilitation training package (CaRe) - Germaine Tan
• Acceptability of an evidence-based booklet for HPV-related oropharyngeal squamous cell carcinoma patients and their partners - Rachael H Dodd
• Co-designing Educational Resources for Left Breast Cancer Patients Receiving Deep Inspiration Breath Hold Radiation Therapy - Kath Dower
• SEAT AT THE TABLE: Elevating consumers to be more than storytellers - Vicki Durston
• Reflecting the consumer voice in a patient education initiative for oncology patients; co-design in the development of a Personalised Care Plan for patients with rectal cancer - Grace Gard
• Codesign of a web-based resource on cardiovascular disease risk in cancer for people affected by cancer and their health care providers - Reegan K Knowles
• Improving carer engagement in cancer care: Mixed methods evaluation of the eTRIO educational module among oncology health professionals - Rebekah Laidsaar-Powell
• Attitudes and Perceptions of Australian Registered Nurses on Prescribing in Cancer and Palliative Care - Jane Lee
• Cancer Support for People of Refugee Background (CSPRBB) - Abbie Lockwood
• Evaluation of a novel national blended learning program for cancer pharmacists - Courtney Oar
• Implementing the Optimal Care Pathway for Aboriginal and Torres Strait Islander people with cancer: a cross-sectional survey of health professionals practicing in Victoria, Australia - Sandra Picken
• Supporting cancer clinicians and researchers to provide culturally inclusive care to Aboriginal and Torres Strait Islander people: an e-learning resource. - Joanne Shaw
• The Impact of Compassionate Care Training for Oncology Pharmacists and Technicians - Whiter Tang
• Climate Change and Cancer: Are we prepared? - Megan Varlow
• Communication skills training for Radiation Therapists to improve First Nations cancer outcomes - Nienke Dr Zomerdijk
• Beyond the First Fight: Secondary Malignancies in Patients from a Private Oncology Practice and the Potential Role of Obesity - Taha Al-Mufti
• National retrospective cohort study of safety and effectiveness of erlotinib and gefitinib in New Zealand for treating EGFR mutated lung cancer: Study protocol and results of the validation sub-study - Phyu Sin Aye
• Impacts of the Victorian COVID-19 lockdowns on the number of cancer patients and stages at presentations to the Gippsland region. - Hieu Chau
•  A review of COVID-19 infections in Australian adult cancer patients of a health service in Southeast Melbourne who received COVID-19 vaccinations. - Arana Hankijjakul
• Real-world REarranged during Transfection [RET]-alteration testing andtreatment patterns of patients with medullary and papillary thyroid cancer [MTC, PTC] in Australia. - Angela Lai
• Outcomes of extensive-stage small-cell lung cancer (ES-SCLC) patients treated with platinum doublet and immunotherapy: A Western Australia retrospective review   - Wei-Sen Lam
• Radiotherapy Utilisation Rates for Older Patients with Head and Neck Cancer in Qld: How do we compare?   - Penny Mackenzie
• Mass Production of Cancer-Related Disinformation Through Artificial Intelligence: An Alarming Case Study - Bradley D Menz
• Intrathyroid metastases - what’s new? - Marie Nguyen
• Prevalence of cancer in Victoria - Luc te Marvelde
• Rapid Diagnostic Clinic: A New Care Model for Suspected Cancer Patients in Regional Areas. - Taha Al-Mufti
• A scoping review of group nutrition education and cooking programs for people affected by cancer - Susannah Ayre
• Developing a bereaved-centred model of bereavement care for an Australian healthcare setting. - Nicci Bartley
• Working title: Exercise Medicine and Allied Health for cancer patients  - Taking research into the real world - Sean Black-Tiong
• Lung Cancer Exercise Services in Australia: A Point Prevalence Study - Amy Bowman
• Implementation of a Clinician-led Digital Health Workflow Review in Prehabilitation   - Amy Bowman
• Exploring Healthcare professionals and Policymakers' Perspectives about the Benefits of a Nurse-Led Telephone Cancer Information Support Service. - Jessica Bucholc
• Unmet Supportive Cancer Care Needs in South Australia - Ryan Calabro
• Lower radiotherapy utilisation in patients with cutaneous T-cell lymphomas (CTCL) living in highly accessible areas - Belinda A Campbell
• Overcoming Challenges in Conducting Systematic Reviews in Implementation Science to Advance Cancer Care - Anna Chapman
• Bridging the gap: Clinical and psycho-social profile of cancer patients attending a psycho-oncology clinic in rural Victoria  - Saji Chathanchirayil
• A comparison of the toxicity profile of oral versus infusion 5-Fluorouracil and the cost-benefit of DPD testing in a regional hospital setting. - Hieu Chau
• Characterising patient safety events among people from culturally and linguistically diverse backgrounds accessing cancer services in Australia: A retrospective medical record review study. - Ashfaq Chauhan
• Cancer Surveillance in Australia: Minimum Follow up Recommendations - Natalie Chilko
• Qualitative perspectives of supportive care priorities from people with lung cancer: a bottom-up approach to value-based healthcare - Holly Chung
• Improving equity in cancer care: clinical utility of a novel nursing checklist to identify social determinants of health in newly diagnosed cancer patients - Holly Chung
• Developing an Education & Career Service for Adolescents and Young Adults with Cancer: A Participatory Intervention Mapping Approach - Jennifer Cohen
• People With Cancer And Health Professional Perceptions Of Willingness To Pay For Exercise Services - Prue Cormie
• Exploring dietitians’ practice and perspectives on the role of dietary patterns during cancer treatment: a qualitative study - Annie R Curtis
• Finding a better way : Defining a strategy for Allied Health across multiple providers in a regional cancer service - Diane Davey
• Can we measure what matters? Feasibility of clinically prioritised colorectal cancer quality indicators with a New South Wales population-based linked dataset - Candice Donnelly
• The medical oncology workforce perceptions of the current measurement and reporting of quality of care in clinical practice - Catherine Dunn
• A modified Delphi study to define and operationalise quality indicators from clinical registry data across sites for metastatic colorectal cancer - Catherine Dunn
• Value Assessment for sustainable translation of exercise oncology interventions - Kim Edmunds
• Prostate Cancer Specialist Nursing Program: A Social Return on Investment - Kim Edmunds
• SUppoRting PAtient-centred SurvivorShip (SURPASS) at St Vincent’s Health Network: Adaptation of the ‘My Personal Plan’ Prostate Cancer Survivorship Care Plan for generic use - Nicola Fearn
• Medical Oncologist Perceptions and Willingness to Participate in Voluntary Assisted Dying in South Australia - Michelle Forgione
• Exploring the difference in travel distances for radiation therapy by tumour type in Victoria, Australia - Piers Gillett
• Cost-effectiveness analysis of the Navigate online treatment decision aid for men with prostate cancer and their partners - Louisa Gordon
• Inclusion and representative diversity in cancer psychological intervention trials - Allison Drosdowsky
• Patient-reported outcomes in routine clinical care: Understanding key steps in the roadmap to implementation - Allison Drosdowsky
• The prevalence of malnutrition and the risk of sarcopenia in immunotherapy treated patients. - Kate Graham
• A CALL TO ACTION: “Equity is a culture” - assessing perceptions of health (in)equity, the current landscape of health services for the development and the implementation of a Cancer Equity Framework. - Tilini Gunatillake
• Co-designing cancer services change with culturally and linguistically diverse communities: Learnings from the CanEngage Project - Reema Harrison
• Co-designing the CanSupport Program with carers of people with cancer in Australia - Reema Harrison
• Exploring Australian Healthcare professionals’ experiences and perceptions of management of older adults with cancer. - Sharon He
• Acceptability of a virtual prostate cancer survivorship care model in regional Australia: Findings from a multi-methods, single centre feasibility pilot - Nicole Heneka
• Real World Outcomes of Patients with Extensive Stage Small Cell Lung Cancer - a Multicenter Australian experience - Martin Hong
• How often are patients recording their medical appointments and why? A national online mixed-methods survey in Australia - Amelia Hyatt
• Survivorship needs of patients following radical treatment for cancer: Five-year results of the Cancer Survivorship Clinic (CSC). - Leah Savage
• Exercise and Cancer Pilot: Prescriptive exercise outside of the healthcare setting   - Donna O'Callaghan
• Cancer Patient Experience Survey (CaPES) in Western Australia - Angela Ives
• Cancer Patient Experience Survey (CaPES) in WA - Angela Ives
• Clinician perspectives on value and clinical utility of risk prediction for checkpoint inhibitor-induced immune-related adverse events (irAE). - Bishma Jayathilaka
• Systems-thinking to optimise dietary and exercise advice and referral practices for cancer survivors in Australia. - Ria Joseph
• A retrospective review of small cell lung cancer in a regional centre in Victoria     - Bridget Josephs
• Improving outcomes of patients with metastatic cancer_ Audit of the Advance Cancer Multi-Disciplinary (ADMDT) Meeting in Gippsland - Sachin Joshi
• Standardising Care for Exercise and Nutrition in Cancer in the South West (SCENIC-SW)  - Mary A Kennedy
• Quality of Decision-Making at Oncology Multidisciplinary Team Meetings: A Structured Observational Study - Youngeun Koo
• Developing strategies for safe and effective integration of Integrative Oncology programs and Wellbeing centres  into comprehensive cancer care in Australia  - Judith Lacey
• Barriers and Facilitators to Electronic Patient-Reported Outcome (ePRO) Symptom Monitoring in Routine Oncology Care- a qualitative study guided by the Consolidated Framework for Implementation Research - Julia Lai-Kwon
• Understanding systems: Mapping Oncology Patient’s journey at an Australian Academic Clinical Trials Unit (CTU) using the Functional Resonance Analysis Method (FRAM) - Cheng Ming Li
• Cancer consumers perspectives on their involvement in health service improvement: A qualitative study - Dan Luo
• The need for a national cancer-specific genomics framework - Helen Hughes
• The effect of exercise interventions on hospital length of stay and admissions during cancer treatment: a systematic review and meta-analysis - David Mizrahi
• Prioritising Collection of CALD identifiers in Cancer Services - Meng Tuck Mok
• A review of Lung Cancer in Gippsland, Victoria. - Cassandra Moore
• Exploring healthcare engagement to improve patient safety in cancer care: a health systems analysis - Reema Harrison
• Cancer Council Australia’s Financial Cost of Cancer Policy - Drew Meehan
• iCanBlend: Blended Psychological Therapy for the treatment of anxiety and depression in adult patients with an experience of cancer – a qualitative interview study. - Kelly F Nunes-Zlotkowski
• Systemic barriers to the provision of professionally-led metastatic breast cancer support groups in Australia: expert interviews with key informants - Fran Boyle
• A scoping review of Australian health service policies governing audio-visual recording - Megan Prictor
• Utilisation of Medicare Chronic Disease Management item numbers for cancer survivors in Queensland, Australia - Md Mijanur Dr Rahman
• Cancer multidisciplinary team meeting governance and quality: a network review and improvement priorities   - Claire Rickard
• Madeline’s Model: Embedding genomics into routine care to meet the lifelong needs of people with cancer and accelerate research - Kate E Roberts
• Review of bereavement resources available at an Australian Healthcare Setting. - Luna Rodriguez Grieve
• A growing cohort: Investigating pharmacy service provision at discharge to outlying cancer inpatients - Lachlan Roth
• Telepharmacy service models for adult outpatients with cancer: a systematic review    - Marissa Ryan
• Advancing the role of the pharmacy technician in cancer services: authorising and checking of compounded parenteral cancer medicines in Australia - Marissa Ryan
• A pilot study to assess the feasibility and acceptability of collecting patient reported outcome and experience data from registry participants with primary epithelial ovarian cancer - Sherine Sandhu
• A review of the Symptom Urgent Review Clinic at The Northern Hospital - Tess Schenberg
• Support group leaders’ perspectives on factors affecting implementation of professionally-led groups for metastatic breast cancer: a qualitative study using Consolidated Framework for Implementation Research (CFIR-2.0)   - Andrea Smith
• The role of systemic therapies in current and emerging opportunities for de-escalation in melanoma: a scoping review protocol - Jennifer Soon
• Prostate cancer treatment variations in men from culturally- and linguistically-diverse backgrounds in Victoria, Australia - Koku Sisay Tamirat
• The oncology day therapy pharmacists’ perception on workload and impact of electronic prescribing - Whiter Tang
• A study protocol for the P-OMICs-flow: Developing a novel precision medicine clinic to drive integration of research into routine healthcare - Shuang Liang
• Ongoing impacts of COVID-19 on new cancer diagnoses in Victoria, Australia - Luc te Marvelde
• COVID-19 impacts on lung cancer diagnosis, management and timeliness in Victoria, Australia: A population based observational study - Luc te Marvelde
• Attributes, benefits, and effectiveness of comprehensive cancer centres: A scoping and systematic review of the international literature - Carla Thamm
• Embedding person-centred oncology nutrition in practice: Implementation of electronic patient-led nutrition screening in the ambulatory cancer care setting - Elise Treleaven
• Early enteral feeding for patients receiving autologous stem cell transplant: When it’s indicated can it be done? - Elise Treleaven
• How do culturally and linguistically diverse cancer survivors use survivorship care plans? - Janette L Vardy
• Putting liver on the agenda: a national roadmap for liver cancer control. - Megan Varlow
• Improving capture of stage at diagnosis by the Victorian Cancer Registry - Luc te Marvelde
• Time from diagnosis to treatment, risk factors and prognostic impact: a cohort study for patients with lung tumours - Jianrong Zhang
• Patient Satisfaction Survey on Telephone Consultations implemented during the Covid-19 Pandemic Era. - Adilah Amil
• Talking Blood Cancer Podcast - Connection through stories - Linda Saunders
• Role of Radiation Therapists in the Provision of Cancer Survivorship Care - Mary-Ann Carmichael
• The Value of Clinical Trials seen through the Lens of Strategic Plans - Duncan Colyer
• Lessons learnt from implementation of an Oncology Nurse Practitioner-led Rapid Access Clinic Expansion (RACE) service at a tertiary regional cancer centre.  - Cassandra Dickens
• Innovating to cross the divide: Establishing Stereotactic Radiosurgey in Central West NSW - Bridgitte Evans
• Expanding Clinical Trials: Teletrial Manager Role & Responsibilities - William Evans
• Palliative radiation therapy in WNSWLHD: evaluating the clinical implications of an innovative and easier access model of care - Matthew Fuller
• Provision of integrated, melanoma-specific clinical psychology services to patients attending outpatient specialist clinics at the Melanoma Institute Australia. - Lisa Gomes
• Cancer@Home: Model of Care Evaluation - Ellen Heywood
• Melanoma in Gippsland – Using Data to Drive Service Development - Caroline Lasry
• Restoring and embedding best practice cancer care in occupational therapy: a service evaluation - Pippa Labuc
• Retrospective Audit of Oncology Inpatients Admitted with Immunotherapy Related Adverse Events - Wei-Sen Lam
• The Cancer Pain App: translating evidence for effectiveness of non-pharmacological strategies to practice - Melanie R Lovell
• Why do healthcare professionals discuss clinical trial participation with some rural cancer patients and not others? - Narelle McPhee
• Willing and able: Learning from our patients to inspire the future of cancer-related malnutrition screening - Louise Moodie
• A model for increasing access to cancer support across Victoria - Alexandra Nolte
• Breaking Barriers, Bridging Cultures: Improving Clinical Trial Access and Participation in the Australian Arabic-Speaking Community - Rayan Saleh Moussa
• Improving the Capture and Reporting of Adverse Events in Clinical Trials of Non-pharmacological Interventions: A PaCCSC/CST Initiative - Rayan Saleh Moussa
• Personalised cancer clinical trials navigator. Empowering cancer patients, driving cancer research. - Kate Saw
• Evaluating patient and healthcare professional experiences of oncology Occupational Therapy Education Sessions: a mixed methods study - Anthea Udovicich
• Student-led exercise physiology clinics in cancer care – a multi-purpose training opportunity - Matthew P Wallen
• Supporting the wellbeing of cancer carers in a comprehensive cancer centre - Peta Wright
• Nothing about us without us: Partnering with consumers to promote clinical trials participation – how we tackled this with ConVICTioN - Vanessa Yenson
• Evaluation of Group Peer Support at a Comprehensive Cancer Centre - Shae Beaton
• Evaluation of an Oncology Massage Service at a Comprehensive Cancer Centre - Shae S Beaton
• Enhancing access to supportive care services for people affected by cancer, how Cancer Council Liaisons make a difference – clients’ perspective. - Katarzyna Bochynska
• Enhancing access to supportive care services for people affected by cancer, how Cancer Council Liaisons make a difference – healthcare professionals’ perspective. - Katarzyna Bochynska
• Testing the efficacy of a single-session online writing intervention on body image and distress in female cancer survivors: A randomized controlled trial.   - Lisa Beatty
• Answering the common questions: LGBTQI+ People and Cancer, a world-first information resource - Jenni Bruce
• The Supportive Care 2030 Movement: Unifying and futuristic ambitions for Supportive Cancer Care. - Raymond J Chan
• Experiences and perspectives of pelvic floor disorders and treatment in women with breast cancer: a qualitative study.   - Udari N Colombage
• Oncology healthcare professionals’ awareness and practice regarding the COSA position statement on exercise in cancer care: Understanding reach and barriers - Jack Dalla Via
• The effect of comprehensive geriatric assessment on care received, treatment completion, and outcomes for older adults receiving systemic anti-cancer treatment: A systematic review - Domenica Disalvo
• The effect of comprehensive geriatric assessment on treatment decisions and care received, and impact on cancer-related and geriatric assessment outcomes for older adults undergoing radiotherapy treatment: A systematic review - Domenica Disalvo
• The impact of comprehensive geriatric assessment on treatment decisions, care received, and postoperative outcomes in older adults with cancer undergoing surgery: a systematic review - Domenica Disalvo
• Exercise Training Improves Persistent Fatigue Following Allogeneic Haematopoietic Stem Cell Transplantation – A Prospective Pilot Study  - Genevieve Douglas
• ExerciseGuide: A qualitative study of patients’ experiences of a web-based personalised exercise intervention for individuals with metastatic prostate cancer  - Holly EL Evans
• Palliative Care Clinical Trials Research in non-Metropolitan settings – opportunities for growth - Miriam Ferres
• CANcer BEhavioural Nutrition and Exercise FeasIbility Trial: early results and lessons learned - Cynthia Forbes
• Perspectives of patients with advanced pancreatic cancer regarding a proposed intensive nutrition intervention: A qualitative investigation  - Kate Furness
• PRehabilitation and Supportive Care in women with Breast cancer (PROactive-B) - Suzanne Grant
• Effectiveness of diet-and-exercise interventions to facilitate dietary and physical activity behaviour change in prostate cancer survivors: a systematic review - Catherine Grigg
• Photovoice, electronic Rapid Fitness Assessment (eRFA) and the This is Me (TiM) Tool for Enhanced Supportive Care Decisions: An implementation Feasibility Cross-sectional Study in a Regional Cancer Centre - Oliver Hodge
• SOCCER: Study of Oncological patients reCeiving COVID-19 vaccines whilst undergoing systemic thERapy for malignancy  - Kristin Hsu
• Effective Management of skin toxicities in cancer treatment: An Australian and New Zealand perspective - Samira Imran
• The impact of implementing a 60-hour methotrexate level on length of stay in patients with osteosarcoma in a tertiary hospital. - Cate Ashwell
• Impact of caring for someone with cancer on the health behaviours of rural caregivers - Lizzy Johnston
• Representativeness Of The ACSM Exercise Guidelines For Cancer Survivors: A Review Of The Contributing Evidence - Tamara Jones
• Enabling health professionals to deliver smoking cessation care: a qualitative study on general practice nurses supporting people to quit smoking - Hannah Jongebloed
• Access to digital health in cancer care: exploring the perspectives of people living rurally and/or with socioeconomic disadvantage. - Emma Kemp
• Prevalence of distress and its associated factors among caregivers of people diagnosed with cancer: A cross-sectional study  - Deborah Kirk
• Prevalence of distress, its associated factors and referral to support services in people with cancer - Deborah Kirk
• Being away from home for cancer treatment: A qualitative study of patient experience and supportive care needs during radiotherapy - Vanessa Knibbs
• Design of Patient-Centered Digital Health Interventions: Leveraging Input from Patients with Brain Tumours for Unmet Supportive Care Needs - Meinir Krishnasamy
• Consensus development of a contemporary framework for cancer supportive care - Meinir Krishnasamy
• Co-design of an online Cognitive Behavioural Therapy (iCBT) intervention for cancer carers with anxiety or depression: Development of CarersCanADAPT - Rebekah Laidsaar-Powell
• Development of a novel NET-nutrition screening tool to identify patients requiring nutrition-related intervention and support - Erin Laing
• Do Australian national, state and territory cancer plans include patient reported outcomes -related objectives and outcomes? - Han Yang Lau
• Improving lymphoedema care in Australia – stakeholders perspective. - Jane Lee
• The role of support groups for people living with metastatic breast cancer in Australia - Andrea Smith
• Defining and implementing a standardised monitoring and reporting process to monitor and communicate alignment with the Optimal Care Pathways. - Sandra Picken
• Survivorship needs in patients with head and neck cancer in regional/remote areas: A qualitative study - Rebecca Venchiarutti
• Thriving at any age, any stage, anywhere: Redefining survivorship support for the blood cancer community. - Linda Saunders
• Does exercise change blood flow to tumours? Acute aerobic exercise effects on liver metastases blood flow: a case series - Catherine Seet-Lee
• Variations in supportive care needs between patients with breast, colorectal, lung, ovarian and prostate cancer in Australia: across-sectional survey - Anna C Singleton
• PD-1 inhibitor induced skin reactions  - Malini Sivasaththivel
• Is malnutrition risk screening enough to identify patients in need of nutrition interventions? - Belinda Steer
• Use of Electronic Geriatric Assessment to Facilitate the Enhanced Supportive Care of Older Adults at an Australian Regional Cancer Centre - Christopher B Steer
• Development and implementation of a Radiation Therapy Talking Book (eBook) for First Nations cancer patients - Lara Stoll
• Terminal delirium related distress is associated with bereaved prolonged grief disorder. - Megumi Uchida
• Clinical and research priorities for the management of multimorbidity in cancer survivors in Australia: a Delphi study - Rebecca L Venchiarutti
• A systematic review and meta-analysis of caregiver fear of cancer recurrence: Levels, measures, and associations - Kyra Webb
• The CARE-FCR: Development and validation of a caregiver-specific measure of fear of cancer recurrence and progression - Kyra Webb
• Eating behaviour and dietary characteristics of long-term prostate cancer survivors - Hattie Wright
• Defining research priorities and needs in cancer symptoms for adults diagnosed with cancer: an Australian/New Zealand modified Delphi study - Vanessa M Yenson
• Examining the role of social support to manage wellbeing among culturally and linguistically diverse cancer caregivers - Eva Yuen
• The mediating role of psychological help-seeking stigma on depression, anxiety, and stress in people with cancer from culturally and linguistically diverse communities - Eva Yuen
• A qualitative examination of the information needs of caregivers of people with cancer from culturally and linguistically diverse backgrounds - Eva YN Yuen
• Empowering rural cancer survivors: Identifying information needs and strategies to meet those needs  - Leah Zajdlewicz
• Counteracting Mental Health Issues In Men With Prostate Cancer Through Exercise - A Randomized Controlled Trial - Eva M Zopf
• Pilot randomised sham-controlled trial of electroacupuncture at onset of chemotherapy-induced peripheral neuropathy (CIPN) in patients with breast cancer. - Victoria Choi
• Trial in progress: BETTER-TRACC – BEnchmarking and Tracking TrEatment and Response inAdvanced Colon Cancer - Catherine Dunn
• Web-based cognitive rehabilitation intervention for cancer-related cognitive impairment following chemotherapy for aggressive lymphoma: a randomised pilot trial. - Priscilla Gates
• Investigating the use of two Delfin Moisture Meter measuring tools - MMDC (Moisture Meter D Compact) and MMEpiD ( Moisture Meter Epidermis D) - for accurate assessment of Post-operative Breast Oedema - Mandy M Goodyear
• “Clinical validation of synergistic effect of Vardhamana Pippali Rasayana along withconventional treatment after unraveling its complex molecular mechanism of action inBreast cancer: From Experimental model to Clinical trial”. - Subhash Gupta
• Supplemental Jejunal Feeding to Improve Quality of Life in Advanced Pancreatic Cancer: Study Protocol for a Randomised Controlled Trial  - Lauren Hanna
• Investigating the nutritional status, outcomes and needs of adolescent and young adults (AYA) following a cancer diagnosis: Protocol for a mixed-methods study - Erin Laing
• Phase II study of Azacitidine and Carboplatin priming for Ipilimumab and Nivolumab re-challenge in patients with advanced melanoma who are resistant to immunotherapy: PRIME005 - Andre van der Westhuizen
• A Phase 3 trial comparing fianlimab (anti-LAG-3) plus cemiplimab (anti-PD-1) to pembrolizumab in patients with completely resected high-risk melanoma - John Crown
• Protocol of a feasibility randomised controlled trial of an intervention to enhance recovery from breast cancer treatment - Janine Porter-Steele
• Bright Light Therapy for the Prevention of Delirium in Hospitalised Adults with Advanced Cancer: A Pilot Feasibility Trial - Rayan Saleh Moussa
• FAPI-CUP - A prospective cohort study of patients with Cancer of Unknown Primary (CUP) to evaluate a novel radiotracer, fibroblast activated protein (FAPI) targeting cancer-associated fibroblasts to improve primary site detection. - Tharani Sivakumaran
• The Sun Wise Study: A randomised controlled trial of a personalised skin cancer prevention strategy among people with a history of skin cancer - Amelia K Smit
• SPADE: Design of a real-world observational study of avelumab first-line maintenance (1LM) in advanced urothelial carcinoma (UC) in the Asia-Pacific (APAC) region - Annalisa Varrasso
• Assessing prevention of chemotherapy induced peripheral neuropathy with cryotherapy - Jocelyn Finney
• Significant durable response with fianlimab (anti-LAG-3) and cemiplimab (anti-PD-1) in advanced melanoma: post-adjuvant PD-1 analysis - John Crown
• A Phase 1 study of fianlimab (anti-LAG-3) in combination with cemiplimab (anti-PD-1) in patients with advanced melanoma: poor prognosis subgroup analysis - John Crown
• A Phase 3 trial of fianlimab (anti-LAG-3) plus cemiplimab (anti-PD-1) versus pembrolizumab in patients with previously untreated unresectable locally advanced or metastatic melanoma - John Crown
• AdvanTIG-105: Phase 1b Dose-Expansion Study of Ociperlimab + Tislelizumab in Patients With Checkpoint Inhibitor (CPI)-Experienced Advanced Non-Small Cell Lung Cancer (NSCLC) - Paul Smart

• Research in demographic transition for breast cancer (thoughts for international and academic collaboration) - Etienne Brain
• Geriatric oncology: The role of the Geriatrician - Heather Lane
• Caring for older individuals with cancer: Musings of a medical oncologist - Michael Krasovitsky
• The role of nursing and allied health in caring for older adults with cancer - Polly Dufton

2:35 PM Panel discussion

COSA Geriatric Oncology Group Meeting                                          Plenary 1

COSA Psycho-Oncology Group Meeting                                            Meeting Room 105

COSA Exercise and Cancer Group Meeting                                       Meeting Room 106

Chair: Sandi Hayes

• How Big of a Problem is Lymphoedema? - Melanie L Plinsinga
• The Quest for Preventing Lymphoedema - Louise Koelmeyer
• Reducing the impact of lymphoedema: conservative management through to surgical approaches - Hildegard M Reul-Hirche
• Impact Of Exercise and Weight Management on Cancer-Related Lymphoedema - Kira Bloomquist
• Dispelling Myths in Lymphoedema Management - Debbie D Geyer

5:15 PM Panel discussion

• Average duration of prior treatment lines predicts clinical benefit to eribulin chemotherapy to patients with metastatic breast cancer - Faye Coe
• New and emerging antibody drug conjugates in breast cancer - Gail Rowan
• Harnessing the immune system in breast cancer - Peter Savas
• Medicines and the microbiome - Olivia Smibert

Chair:  Marion Saville

• Overview of the Australian and global strategies  - Karen Canfell
• Implementation strategies for improving uptake of vaccination and screening?  - Julia Brotherton
• Achieving cervical cancer elimination in Aboriginal and Torres Strait Islander communities - Lisa J Whop
• Self-collection eligibility expansion overcoming barriers and improving uptake in the National Cervical Screening Program in Australia - Farhana Sultana

5:00 PM Panel discussion 

• Cost-utility analysis of a telehealth psychological support intervention for people with primary brain tumour: Telehealth Making Sense of Brain Tumour - Louisa G Gordon
• Striving towards better assessment of physical activity and sedentary behaviour: A novel cluster analysis approach using wrist accelerometry in childhood cancer survivors - Lauren Ha
• Pain and its interference with daily living in relation to cancer: a comparative population-based study of 16,053 cancer survivors and 106,345 people without cancer - Bogda Koczwara
• Potential impact of exercise upon symptom burden in adolescents and young adults undergoing cancer treatment. - Claire Munsie
• Financial toxicity among rural cancer survivors in Gippsland, Victoria, Australia - Eli Ristevski
• Does caregiver and cancer patient health literacy, social support and connectedness impact caregiver psychological morbidity? - Eva YN Yuen

• A parent-led program to promote healthy eating habits in children living beyond cancer: A pilot randomised-controlled trial. - Jennifer Cohen
• Exercise Conversations: A Mixed Methods Study Explaining What Health Professionals Require To Embed Exercise Recommendations Into Routine Cancer Care - Prue Cormie
• Training Healthcare Interpreters about Cancer Clinical Trials - Suzanne Grant
• Implementation of a prehabilitation model of care using co-designed resources for head and neck cancer patients undergoing radiotherapy  - Ella Sexton and Hannah Ray
• Lung Cancer (internet-based) Delphi (LuCiD) : a modified eDelphi consensus to establish Australasian thoracic oncology clinical quality indicators - Shalini Vinod
• Consensus Recommendations For Genetic Testing In Prostate Cancer: A Delphi Study - Haitham Tuffaha

This dinner is especially for our trainees in any specialty of breast cancer management. We will hear the important surgical, plastics, radiation and medical oncology perspectives of how to treat high risk early breast cancer. The challenges for the patient and the clinician in working out what treatment to give, in what order and what imaging and pathological information is required to make these informed decisions.

We look forward to a fun night to meet your colleagues in related disciplines of breast cancer care!

Chair:

• Dr Belinda Yeo, Medical Oncologist and Clinician Scientist, Austin Health

Guest speakers:

• A/Prof Steven David (Radiation Oncologist), Peter MacCallum Cancer Centre

• Dr Satomi Koide (Plastics Surgeon), St Vincent’s Hospital, Melbourne

• Prof Bruce Mann (Breast Surgeon), Director of the Breast Tumour Stream, Victorian Comprehensive Cancer Centre

• A/Prof Louise Nott (Medical Oncologist), Medical Oncologist, Royal Hobart Hospital

This meeting is financially sponsored by Novartis. The content and agenda have been developed independently by COSA and medical experts.

Fight with Care is the new program from La Roche Posay working to highlight the importance of a holistic approach when treating oncology treatment side effects. We welcome you to join us for an evening with the scientific experts behind the campaign, discussion around the treatment guidelines and management of skin toxicities in oncology patients and discover the work we do, in partnership with the McGrath foundation, to drive better access for patients who experience skin toxicities as a result of their cancer therapy.

Skin toxicities

Fight with Care program launch incl. Onco-dermatology clinic at Princess Alexandra Hospital

Speakers:

• Associate Professor Victoria Mar

• Samantha Russel - Medical Director of L'Oreal Dermatological beauty

• More to be confirmed

Pharmacist Prescribing in Cancer - Are we getting close?

Pharmacists are already actively providing excellent care to cancer patients during pre-admission, treatment and discharge or transition planning. The role of a clinical pharmacist has evolved, pharmacists are providing valuable advice to the medical team after reviewing medication related issues of the patients. While there have been proposals and trial initiatives in the community setting, pharmacist prescribing in Australia is currently very limited. In contrast, pharmacists have been prescribing in the UK since 2003.

How did they get there? What can we learn from our colleagues from UK? What are some of the challenges the pharmacist prescribers faced?

In this symposium we will have discussion of the UK model, how it works and the advanced pharmacist practice happening in Australia, including Partnered Pharmacist Medication Charting.

The Partnered Pharmacist Medication Charting (PPMC) Model has been tested and implemented in Victoria in both general medicine and more recently in the oncology setting. Under the PPMC model, pharmacists have been placed in a unique position to review, document and co-chart medications with the prescriber.

Is PPMC a step towards pharmacist prescribing and advanced practice? Would it be a basis of pharmacist prescribing? How can we work towards an advanced practice pharmacist model?

Come to the dinner symposium and find out!

Speakers:

• Faye Coe, Advanced Clinical Oncology Pharmacist, Leeds Teaching Hospitals, NHS Trust, UK

• Gail Rowan, Advanced Clinical Training & Medicines Information Senior Pharmacist, Peter MacCallum Cancer Centre